Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Engineering of intrinsically zirconium-89 radiolabeled self-destructing mesoporous silica nanostructures for in vivo tumor vasculature targeting

Shreya Goel, Feng Chen, Sixiang Shi, Hector Valdovinos, Todd Barnhart and Weibo Cai
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1151;
Shreya Goel
3University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Feng Chen
1University of Wisconsin - Madison Madison WI United States
2University of Wisconsin - Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sixiang Shi
3University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hector Valdovinos
3University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Todd Barnhart
3University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weibo Cai
1University of Wisconsin - Madison Madison WI United States
2University of Wisconsin - Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 57 no. supplement 2 1151

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2016.

Copyright & Usage 
© 2016

Author Information

  1. Shreya Goel3,
  2. Feng Chen1,2,
  3. Sixiang Shi3,
  4. Hector Valdovinos3,
  5. Todd Barnhart3 and
  6. Weibo Cai1,2
  1. 1University of Wisconsin - Madison Madison WI United States
  2. 2University of Wisconsin - Madison Madison WI United States
  3. 3University of Wisconsin-Madison Madison WI United States

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2016 to April 2025

AbstractFullPdf
May 2016200
Jun 20161600
Jul 2016800
Aug 20161200
Sep 2016400
Oct 20161400
Nov 2016800
Dec 2016700
Jan 2017600
Feb 20171200
Mar 2017900
Apr 20171000
May 2017500
Jun 2017500
Jul 2017100
Aug 2017300
Sep 2017600
Oct 2017400
Nov 20172400
Dec 2017100
Jan 2018300
Feb 2018200
Mar 2018200
Apr 2018200
May 2018300
Jun 2018100
Aug 2018400
Sep 2018300
Oct 2018400
Nov 2018500
Feb 2019700
Mar 2019400
Apr 2019100
May 2019500
Jun 2019700
Jul 2019400
Aug 2019200
Oct 2019100
Dec 2019400
Feb 2020500
Mar 20201600
Apr 20201100
May 2020300
Jun 2020100
Jul 2020400
Aug 20201600
Sep 20203100
Oct 20201800
Nov 20202000
Dec 20201800
Jan 2021300
Feb 2021800
Mar 2021600
Apr 20211000
May 2021700
Jun 2021200
Jul 20211500
Aug 20213200
Sep 20211200
Oct 20211700
Nov 20214900
Dec 20214300
Jan 20227500
Feb 20222100
Mar 20222000
Apr 20224200
May 20223200
Jun 2022300
Aug 2022200
Sep 2022200
Oct 2022400
Nov 2022200
Dec 2022100
Jan 2023300
Feb 2023400
Mar 2023300
Apr 2023100
May 2023200
Jun 2023300
Jul 2023200
Aug 2023500
Sep 2023200
Oct 2023400
Nov 2023600
Dec 2023300
Jan 2024300
Feb 2024200
Mar 2024200
Apr 2024200
May 2024800
Jun 2024600
Jul 2024100
Aug 2024900
Sep 2024600
Oct 2024100
Nov 2024500
Jan 2025300
Feb 2025100
Mar 2025700
Apr 2025100
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Engineering of intrinsically zirconium-89 radiolabeled self-destructing mesoporous silica nanostructures for in vivo tumor vasculature targeting
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Engineering of intrinsically zirconium-89 radiolabeled self-destructing mesoporous silica nanostructures for in vivo tumor vasculature targeting
Shreya Goel, Feng Chen, Sixiang Shi, Hector Valdovinos, Todd Barnhart, Weibo Cai
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1151;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Engineering of intrinsically zirconium-89 radiolabeled self-destructing mesoporous silica nanostructures for in vivo tumor vasculature targeting
Shreya Goel, Feng Chen, Sixiang Shi, Hector Valdovinos, Todd Barnhart, Weibo Cai
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1151;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

SPECIAL MTA: Preclinical Probes for Oncology Posters

  • Selective Targeting of Melanoma Tumor by F-18 Fluorobenzamide (F-18 FBENZ): Tracer Kinetics and Preclinical Assessment in Mouse Model using MicroPET.
  • Synthesis and Evaluation of 18F-AmBF3-PSMA Derivatives as PET Imaging Agents for Prostate Cancer
  • In vivo E-cadherin expression assessed with radiolabeled E-cadherin antibodies: a potential target to image epithelial-to-mesenchymal transition in vivo.
Show more SPECIAL MTA: Preclinical Probes for Oncology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire